Should You Invest in Taysha Gene Therapies Inc (TSHA) Now?
The 36-month beta value for TSHA is at 0.34. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0
The 36-month beta value for TSHA is at 0.34. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0
The stock of Taysha Gene Therapies Inc (TSHA) has seen a 2.98% increase in the past week, with a -10.70% drop in the past month,
Taysha Gene Therapies Inc (NASDAQ: TSHA) has seen a rise in its stock price by 2.85 in relation to its previous close of 2.46. However,
Taysha Gene Therapies Inc (NASDAQ: TSHA)’s stock price has decreased by -0.94 compared to its previous closing price of 2.66. However, the company has seen
Taysha Gene Therapies Inc (NASDAQ: TSHA) has seen a rise in its stock price by 14.18 in relation to its previous close of 2.68. However,
The 36-month beta value for TSHA is also noteworthy at 0.28. There are mixed opinions on the stock, with 7 analysts rating it as a
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.